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Heart rate variability (HRV) is regarded as a useful, non-invasive method for 
investigating the autonomic nervous system (ANS). Over the past decade there has been 
an increase in the number of HRV investigations in the disciplines of medical, sport and 
exercise science. Despite the extensive use of HRV in investigations of ANS 
functioning, there are questions relating to the reliability of the technique. Therefore, 
HRV reliability studies for different population groups have been advocated. 
Furthermore, research on gender differences in HRV is contradictory. This has resulted 
in the need to investigate gender characteristics in HRV. 
 
Objectives 
The objective of this study was to evaluate the reliability of short-term (5min) 
recordings of HRV, and to determine the association between HRV and gender. 
 
Methods 
Forty four physically active students (n= 21, age= 21.17 (1.55) males and n=23, age= 
19.75 (1.76) females) participated in the study. Heart rate variability parameters were 
determined from five minute recording of interbeat intervals (IBI) using a Suunto t6 
heart rate monitor (HRM). Testing was repeated over 4 consecutive days under the 
same conditions. The following HRV time and frequency domain measures were 
calculated using Kubios HRV Software Version 2.0: mean heart rate (HR), standard 
deviation of normal to normal intervals (SDNN), root mean square of successive 
differences (RMSSD), percentage of beats that changed more than 50 ms from the 
previous beat (pNN50), low frequency in normalized units (LFnu), high frequency in 
normalized units (HFnu) and low frequency to high frequency ratio in normalized units 
(LF/HFnu ratio). The data was summarized using routine descriptive statistics. Relative 
reliability was calculated using interclass correlation coefficients (ICC) (ICC of >0.80 
indicated good to excellent reliability) and absolute reliability using typical error of 
measurement (TEM) and TEM as a percentage of the mean score (TEM%). This 
statistical measures were computed for days 2 vs 3 (REL 1), 3 vs 4 (REL 2). Day 1 was 
used as a familiarization day. An unpaired T-test was used to determine whether there 
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were any differences between males and females for the above HRV parameters. 
Significance was set at p ≤0.05. 
 
Results 
The ICCs for both REL 1 and REL 2 indicated good to excellent (ICC >0.8) reliability 
for IBIs and pNN50 for the time domain results. In general, the time domain results had 
a higher relative reliability than the frequency domain results. Males had an overall 
lower relative reliability than females for frequency domain parameters. Absolute 
reliability for REL 2 showed a slightly lower TEM value as compared to REL 1.The 
largest gender differences in TEM were seen in the frequency domain parameters. 
Specifically, for males, the TEM was higher than females for the LF/HFnu ratio (REL 
2: 116%), the HFnu (REL 1: 90%) and the LFnu (REL 1: 68%). Overall the TEM% was 
relatively high in most HRV parameters specifically for LF/HFnu (REL 1: 31.4% 
females and 48.1% males; REL 2: 29.7% females and 40.4% males). These findings 
indicate that males have decreased absolute reliability compared to females and that 
random error is greater in men for the frequency domain parameters. Gender differences 
illustrated significant differences for resting HR (16% higher in females (p < 0.0001)), 
IBIs (21% higher in females (p <0.0001)) and LF/HFnu ratio (41% higher in males (p = 
0.003)). The findings indicate that females have higher total HRV. 
 
Conclusions 
Short term recordings of HRV over consecutive days using the Suunto t6 HRM and 
Kubios custom HRV software are reliable depending on the HRV parameter being 
analysed. Overall, the relative reliability results suggest that HRV using the Suunto t6 
and Kubios is good. However, the absolute reliability results suggest low reliability. In 
particular, males demonstrated a poorer absolute reliability (high TEM and TEM%) 
than females, suggesting a larger day to day random error in males. Furthermore, 
specific HRV measures differed between males and females demonstrating that females 
have higher parasympathetic modulation compared to men. The overall higher HRV in 
females could explain the possible cardio-protective mechanism observed in 
premenopausal women.  
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The autonomic nervous system (ANS) governs many of the body’s internal functions, 
through its two pathways, the sympathetic (SNS) and parasympathetic (PNS) nervous 
systems. The cardiovascular (CV) system, in particular the heart rate (HR), is mostly 
regulated by the ANS via the activity of these two pathways. (Borresen and Lambert, 
2008) and (Aubert et al., 2003) acknowledge that the analysis of heart rate variability 
(HRV) provides information about the functioning of the ANS. 
 
A number of different tools have been used to measure and monitor the CV system; 
they include electrocardiography (ECG), echocardiography, and HRV. The first two 
tools show electrical and structural changes, whilst HRV is a measure of the time 
intervals or interbeat intervals (IBIs) between each QRS complex (Berkoff et al., 2007). 
Heart rate variability may most simply be described as the frequency with which the 
IBIs changes in a set period of time (Tarvainen and Niskanen, 2008). The analysis is 
divided into time and frequency domains (Aubert et al., 2003). Changes in the domains 
of HRV reflect changes in autonomic modulation of the heart both within a single 
recording or over time (Nagai and Moritani, 2004).  
 
The data obtained from the analysis of HRV provides information about the about ANS 
functioning, which has relevance for the understanding of physical, emotional, and 
mental functioning (Pinna et al., 2007) . High HRV is an adaptive quality in a healthy 
body (Algra et al., 1993), whilst low HRV has been linked to a number of disease states 
including coronary heart disease (CHD), diabetes (Keenan and Grossamn, 2006) and 
depression (Earnest et al., 2004)  as well as overtraining and poor recovery in athletes 
(Seiler et al., 2007). 
 
In a variety of circumstances, increased HRV is associated with lower mortality rate 
(Nagai and Moritani, 2004).  It has been demonstrated that trained individuals have a 
higher HRV than sedentary individuals, suggesting that exercise training can increase 
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HRV in normal populations (Nagai and Moritani, 2004). The use of HRV to measure 
and monitor the impact of training, recovery, health and other related physiological 
events has the potential to improve health and performance (Sinnreich et al., 1998, 
Berkoff et al., 2007). 
 
Scientific study of the variability in HR is fairly new. In recent years, the use of HRV as 
a clinical tool has increased and so too has research pertaining to its reliability (Pinna et 
al., 2007). Although such a broad use of this methodology would assume that the 
reliability of HRV measurements has been thoroughly evaluated, the evaluation has 
often been inadequate (Sandercock et al., 2007). Therefore, despite its extensive use in 
physiological and clinical research, the analysis of HRV is still poorly supported by 
thorough reliability studies (Pinna et al., 2007). Furthermore, gender characteristics 
discussed in the literature of HRV are contentious. Most of the research that includes 
differences between males and females has been inadvertent (Dietrich et al., 2006, 
Kristal-Boneh et al., 2002). The research on gender differences indicated that females 
may have a cardio-protective mechanism, which suggests that women would have a 
higher parasympathetic tone compared to males (Ramaekers et al., 1998). There is 
currently limited research worldwide and in South Africa relating to the reliability and 
gender aspects of HRV.  
 
The aim of this study was therefore to evaluate the reliability of short-term recordings 










CHAPTER 1: LITERATURE REVIEW 
 
1.1 Introduction 
An individual’s adaptation to psychological and physical stressors is met in part by the 
autonomic nervous system’s (ANS) control of the body’s cardiovascular (CV) system 
(Tortora and Grabowski, 2000). The effect of the ANS can be understood through the 
measurement of heart rate variability (HRV). To determine whether HRV is a viable 
marker of ANS functioning, it is important that validity and reliability of the HRV 
parameters are established (Taskforce, 1996). Currently, there is limited research 
available examining the reliability of HRV measurements (Umetani et al., 1998), 
(Ramaekers et al., 1998, Pinna et al., 2007, Nunan et al., 2009, Sinnreich et al., 1998). 
In addition, gender influences HRV but research on this aspect is controversial 
(Sinnreich et al., 1998, Umetani et al., 1998, Ramaekers et al., 1998). This review will 
firstly, examine the physiological mechanisms underpinning the concept of HRV. 
Secondly, it will examine current HRV research, including its use in health and 
athletic/sport performance settings and the influence of gender and ageing on HRV. 
Finally, it will discuss the validity and reliability studies that have been performed in the 
area. 
 
1.2 Autonomic Nervous System and Heart Rate Variability  
The ANS is portrayed as the neurological ‘pacemaker’ of the CV system as it acts on 
the Sino-Atrial Node (SA Node) of the heart (Opie, 1991). The CV system is mostly 
controlled by ANS regulation through the activity of the sympathetic (adrenergic) and 
parasympathetic (vagal or cholinergic) pathways. The sympathetic branch of the ANS 
augments HR while the parasympathetic branch decreases HR. The vagus nerve plays a 
role in mediating the parasympathetic pathway through the release of acetylcholine. The 
effect of any vagal impulse is brief because the acetylcholine is rapidly hydrolysed 
(Faulkner et al., 2003). Acetylcholine results in slowing of both the activity at the SA 
node and cardiac impulses, which ultimately reduces HR. The SNS exerts its influence 
by releasing the neurotransmitter norepinephrine at the sympathetic nerve endings. This 
stimulation increases the rate of SA node discharge and accelerates atrioventricular 
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conduction of impulses (Lopes and White, 2006). Under resting conditions, in healthy 
individuals, parasympathetic tone overrides sympathetic tone (Lopes and White, 2006). 
Parasympathetic influences exceed sympathetic effects probably via two independent 
mechanisms: a cholinergically induced decline of norepinephrine released in response 
to sympathetic activity, and a cholinergic attenuation of the response to an adrenergic 
stimulus. The influence and balance that these two branches of the ANS exert on the 
heart has been termed the sympathovagal balance (Keenan and Grossamn, 2006). The 
measurement of HRV has been used as a non-invasive tool to examine sympathovagal 
balance (Sandercock et al., 2005). 
 
1.3 Definition of Heart Rate Variability 
Heart rate variability depicts the modulation of the CV system by the ANS and other 
physiological regulatory systems (Tortora and Grabowski, 2000). The numerous 
measures of HRV reflect the fluctuations or variability of the changes in the interval, or 
time between R-waves during a specified time of HR recording (Lopes and White, 
2006). These R-wave time intervals are called RR intervals or interbeat intervals (IBIs) 
and are measured in milliseconds (Algra et al., 1993) (Figure 1.1). Breathing or 
respiration plays an important role in HRV. In a controlled atmosphere in which 
respiration is accounted for, IBIs lengthen with expiration and shorten with inspiration 
(Lopes and White, 2006).  
 
Multiple biological rhythms overlay one another to produce the resultant pattern of 
HRV. Heart rate variability has relevance for understanding the effect of acute and 
chronic stressors on physical, emotional, and mental functioning (Taskforce, 1996). 
Increased variability in HR IBIs is an adaptive quality of a healthy body (Algra et al., 
1993).  Lower HRV has been reportedly linked to increased risk of cardiovascular 
disease (CVD) (Moodithaya and Avadhany, 2009). This decrease in variability has been 
proposed as a shifting of cardiac autonomic balance towards sympathetic dominance, 
compared to parasympathetic activity which prevails under normal, healthy, resting 
conditions (Moodithaya and Avadhany, 2009). Sympathetic hyperactivity has been 
linked to the development of atherosclerosis, CV hypertrophy, cardiac arrhythmia and 





Figure 1.1: Diagram depicting RR Intervals (Tarvainen et al., 2008). 
 
1.4 Mechanisms Regulating Heart Rate Variability 
1.4.1 The Cardiovascular Neural Regulation Model 
The regulation of the heart is under the control of the medulla oblongata (brain stem) 
which is in the CV centre. This CV centre has the ability to influence and direct suitable 
output by increasing or decreasing the frequency of nerve impulses via the two branches 
of the ANS (Tortora and Grabowski, 2000). 
 
 
The neural regulation of circulatory functions is principally accomplished through the 
excitatory influences of sympathetic and parasympathetic outflows, which are 
modulated by at least three major factors: 1) central integration, 2) peripheral inhibitory 
baroreceptor vagal reflex mechanisms (with negative feedback characteristics), and 3) 
peripheral inhibitory excitatory sympathetic reflex mechanisms (with positive feedback 
characteristics) (Taskforce, 1996).  
 
 
Figure 1.1 provides a schematic representation of the Cardiovascular Neural Regulation 
Model. From the figure it can be seen that opposite feed back mechanisms, originating 
in the brain, have an affect on the neural control of the CV system. The regulation of 
blood pressure (BP) controls the negative feed back mechanisms that results in the HRV 
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pattern  (Lopes and White, 2006). Baroreceptors monitor changes in pressure and 
stretch in the walls of the blood vessels. Even if BP is normal, the distribution of blood 
flow may require adjustment.  The baroreceptors detect an increase in BP which results 
in an increased parasympathetic stimulation via the vagus nerve and a decrease in 
sympathetic stimulation. This outcome decreases HR.  Baroreceptor and vagal afferent 
fibers from the cardiopulmonary region mediate negative feedback mechanisms 
(exciting the vagal and inhibiting the sympathetic outflow). Conversely if BP rises, the 
baroreceptors are stretched less and send impulses at a decreased rate to the medulla 
oblongata which results in decreased parasympathetic activity and increased 
sympathetic activity. Sympathetic afferent fibers mediate positive feedback mechanisms 
(exciting the sympathetic and inhibiting the vagal flow) (Lopes and White, 2006,  
(Taskforce, 1996, Tortora and Grabowski, 2000). 
 
 
Figure 1.2: Diagrammatic Representation of Autonomic Regulation of the Heart                     





1.5 Heart Rate Variability Frequencies and Parameters 
 
Variations in HR may be evaluated by a number of methods including time domain 
(statistical measures), geometric methods, frequency domain (spectral analysis) and 
nonlinear methods (Roy et al., 2009). Heart rate variability time domain parameters 
include the following: 1) standard deviation of NN (normal to normal) or normal IBIs 
(SDNN), 2) percentage of adjacent RR intervals that varied by more than 50ms 
(pNN50), and 3) the root mean square of the difference between the coupling intervals 
of adjacent IBIs (RMSSD) (Taskforce, 1996, Lopes and White, 2006). These may be 
divided into two classes, (a) those derived from direct measurements of the IBIs or 
instantaneous HR (e.g. SDNN), and (b) those derived from the differences between IBIs 
(e.g. RMSSD) (Taskforce, 1996).  
 
 
Geometric methods are a result of series of NN intervals which are converted into 
geometric patterns, such as RR triangular index and triangular interpolation of NN 
(TINN) (Lopes and White, 2006). The major advantage of geometric methods lies in its 




Spectral analysis or frequency domain methods for the study of tachograms have been 
used for many years. Power spectral density (PSD) examination provides an 
understanding of sympathetic and parasympathetic effects on HRV (Lopes and White, 
2006) and presents basic information of how power distributes as a function of 
frequency (Taskforce, 1996). The advantage of the frequency domain measure over 
time domain is that the frequency measures provide more data and explanation of the 
contributions of sympathetic and parasympathetic activity (Lopes and White, 2006). 
 
 
Heart rate variability is frequently estimated by means of spectral analysis in which 
power in three or four frequency bands is determined (Keenan and Grossamn, 2006). 
Three main spectral components are distinguished in a spectrum calculated from short 
term recordings of 2 to 5 minutes: very low frequency (VLF), low frequency (LF), and 
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high frequency (HF) components. The distribution of power and the central frequency 
of LF and HF are not fixed but may vary in relation to changes in autonomic 
modulations of the heart period. The physiological explanation of the VLF component 
is much less defined and the existence of a specific physiological process attributable to 
these heart period changes might even be questioned. VLF assessed from short-term 
recordings (e.g. <5 min) is an uncertain measure and should be avoided when 
interpreting the PSD of short-term ECGs (Taskforce, 1996).  
 
 
Measurement of VLF, LF and HF power components is usually made in absolute values 
of power (ms2), but LF and HF may also be measured in normalized units (n.u.) which 
represent the relative value of each power component in proportion to the total power 
minus the VLF component (Roy et al., 2009). The representation of LF and HF in n.u. 
emphasizes the controlled and balanced behavior of the two branches of the ANS. 
Moreover, normalization tends to minimize the effect on the values of LF and HF 
components of the changes in total power (Taskforce, 1996). Heart rate recordings of 
approximately 1 min are needed to assess the HF components of HRV while 
approximately 2 min are needed to address the LF component. In order to standardize 
different studies investigating short-term HRV, 5 minute recordings of a stationary 




Power spectral density provides basic information of how power or variance distributes 
as a function of frequency (Taskforce, 1996). Psychophysiological research suggests 
that the HRV frequency ranges reflect different biological influences (Lopes and White, 
2006). The LF component has been proposed as reflecting both sympathetic and 
parasympathetic effects on the heart and generally occurs in a band between 0.04 Hz 
and 0.15 Hz. However, researchers noted that the LF peak is influenced by the 
baroreceptors mediated regulation of BP and reflects predominantly sympathetic 
activity (Moodithaya and Avadhany, 2009). The influence of vagal efferent modulation 
of the SA node can be seen in the HF band, loosely defined between 0.15 and 0.4 Hz 
and known as respiratory sinus arrhythmia (RSA) because it occurs at the respiratory 
frequency (Lopes and White, 2006). The ratio of power in the LF and HF components 
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(LF/HF ratio) has been used to provide an estimate of cardiac sympathovagal balance 
and can assess the fractional distribution of power (Aubert et al., 2003, Keenan and 
Grossamn, 2006). Chemoreceptor processes, thermoregulation, and the rennin-
angiotensin system have been tied to VLF (Keenan and Grossamn, 2006). The VLF 
range is associated with sympathetic activation (Lopes and White, 2006).   
 
 
Nonlinear analysis of HRV is a technique that makes fundamentally different 
assumptions about the data as compared to time and frequency domain analysis. These 
methods assume that much of the behaviour is irregular but still not random. They are 
not designed to assess the magnitude of variability but rather they estimate the 
correlation of properties and the complexity of HRV. Researchers use this analysis to 
investigate rapid dynamic changes (i.e. during exercise, hypertension) in ANS (Lopes 
and White, 2006). There are many techniques of nonlinear analysis but in the field of 
sport and exercise the Poincar´e plot is widely used. It provides a graphical depiction of 
CV dynamics which is in an elliptical shape. It is a scattergram in which each IBI is 
plotted as a function of the previous IBI. For example a healthy young individual at rest 
would demonstrate  high HRV and this would be seen by a big ellipse as compared to 
an older individual who would have reduced HRV and therefore a reduced ellipse 
(Lopes and White, 2006). 
 
1.6 Heart Rate Variability and Health 
1.6.1 Cardiovascular Disease  
Experimental evidence for a connection between a predisposition for lethal arrhythmias 
and signs of either reduced vagal activity or increased sympathetic activity encouraged 
the development of quantitative markers of autonomic activity (Taskforce, 1996). Heart 
rate variability measurements have been validated and represent one of the most 
promising markers of ANS function (Algra et al., 1993, Nunan et al., 2009).  
 
The clinical relevance of HRV was first appreciated in 1965 when Hon and Lee noted 
that fetal distress was preceded by alterations in IBIs before any appreciable change 
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occurred in the HR itself (Taskforce, 1996). Research over the past few decades has 
demonstrated a significant relationship between the ANS and CV mortality, including 
sudden cardiac death (Taskforce, 1996) with HRV, and the quantification of its spectral 




After adjusting for known risk factors, reduced HRV was associated with progressing 
age and with an increased risk of cardiac events in clinically disease-free patients 
(Nagai and Moritani, 2004a). Lower HRV was proven to be associated with a greater 
risk for developing hypertension among normotensive men, and hypertension is one of 
the major risk factors of CHD. Acute myocardial infraction is accompanied by a 
decreased HRV, which is due to reduced vagal or increased sympathetic outflow to the 
heart (Lui et al., 2003). Reduced HRV in short-term recordings (2 hours) was shown to 
predict new cardiac events, hypertension and hyperglycaemia, in a middle-aged general 
population (Dietrich et al., 2006). Dietrich et al (2006) found associations between 
social position, behavioural factors, components of the metabolic syndrome, and HRV. 




1.6.2 Obesity and Diabetes 
Decreased values of HRV has been shown to be indirectly proportional to BP, body 
mass index (BMI) and hyperinsulinemia in obese adults and young patients without 
clinical symptoms of CVD, diabetes or damage of the target organ (Keenan and 
Grossamn, 2006).  
 
 
Autonomic nervous system dysfunction has been documented in obese adults but there 
is limited information relating to ANS dysfunction in obese children. In one study, that 
investigated ANS function in childhood (7±13 years of age) obesity, there was normal 
activity of the SNS, and hypoactivity of the PNS. The authors concluded that PNS 
dysfunction is a risk factor in childhood obesity (Yakincia et al., 2000). Furthermore, 
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Nagai et al. (2004) showed that obese children possess decreased SNS activity as well 
as PNS activity compared to lean children who have similar physical activity levels. 
This ANS activity reduction, associated with the amount of body fat in inactive state, 
could be an etiological factor for the onset or development of childhood obesity. 
Regular physical activity has also been shown to have a favorable influence on 
parasympathetic activity (Gutin et al., 2000). Overall ANS activity in both lean and 
obese children has been shown to be improved with physical activity. The findings of 
Nagai et al. (2004) demonstrated that regular physical activity might be effective in 
preventing and treating obesity associated ANS dysfunction in children. 
 
Research has suggested that factors such as physical activity level, may lead to a 
different profile of sympathovagal activity in obese individuals. The findings of several 
cross-sectional and interventional research studies have shown that increased physical 




1.6.3 Mental Health, Stress and Depression 
Studies have also shown that clinical depression may be linked to decreased HRV 
(Earnest et al., 2008). Heart rate variability measurements can also be sensitive to stress 
and can be seen to decrease with age, which has been attributed to a decrease in efferent 
vagal tone (Keenan and Grossamn, 2006). Effective emotional regulation depends on 
being able to flexibly adjust your physiological response to a changing environment. 
Increased stress has been linked to a greater risk of developing chronic diseases (Tortora 
and Grabowski, 2000). The body’s stress response includes an increase HR which is a 
result of increased sympathetic activity (Taskforce, 1996). This stress causes increased 
hormone release, which enhances cardiac contractility resulting in tachycardia at rest 








1.7 Heart Rate Variability, Exercise and Performance 
Regular exercise training can lead to positive CV changes (Berkoff et al., 2007). 
Different types of exercise training (aerobic, resistance training) have different 
physiological and physical impacts on the ANS.   
 
Research has shown that trained athletes have a higher HRV than sedentary individuals 
and that exercise training can increase HRV in normal populations (Nagai and Moritani, 
2004). Overtraining is characterized by reduced performance and marked fatigue and is 
a result of increased training load coupled with decreased quality recovery (Lopes and 
White, 2006). Heart rate variability has been shown to be reduced in athletes with the 
overtraining syndrome (Sandercock et al., 2005). Sandercock et al. (2005) examined 
ANS activity in several middle distance runners and found that heavy training shifted 
the cardiac autonomic balance towards a predominance of the sympathetic over 
parasympathetic drive. When recorded during the night, HRV appeared to be a better 
tool than resting HR to evaluate cumulated physical fatigue, because it magnified the 
induced changes in ANS activity (Sandercock et al., 2005).  
 
ANS recovery is more rapid in highly trained than in trained subjects after high 
intensity exercise (Seiler et al., 2007). The high frequency training ensures that these 
adaptive effects are cumulative. Conversely, incomplete recovery from frequent training 
can make the stress related side effects cumulative as well. The day to day distribution 
of training intensity may be a crucial variable to effectively balance negative stress 
effects and positive adaptive effects so that performance development is achieved 
without stagnation or overtraining (Seiler et al., 2007). 
 
Exercise training enhances total HRV in normal older adults. The most predominant 
alterations are in nocturnal HR (Nagai and Moritani, 2004). Studies have shown that 
endurance athletes have an elevated level of parasympathetic tone in comparison to 
sedentary people. The effect of resistance training on autonomic tone is less clear. Elite 
athletes have been shown to have higher parasympathetic tone than recreational athletes 
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and non athletes (Berkoff et al., 2007). Persons who are more physically active show a 
wider range between their maximal and minimal HR. Chronic exercise training 
produces a resting bradycardia that is thought to be due partly to enhanced 
parasympathetic modulation (Nagai and Moritani, 2004).  
 
The assessment of HRV in postmenopausal women is essential because CVD typically 
occurs later in women than in men, with CVD being one of the two leading causes of 
death in women (Ribeiro et al., 2001). Changes in lifestyle and the inclusion of physical 




Earnest et al. (2008) conducted research on postmenopausal women participating in 
exercise training over a 6 month period. Their primary findings were that moderate 
intensity exercise training improves HRV characteristics in previously sedentary, 
overweight or obese postmenopausal women. It has been reported that normal aging 
influences indices related to CV function, including the adrenoreceptor responsiveness 
and baroflex sensitivity which results in decreased parasympathetic activity (Tortora 
and Grabowski, 2000), (Earnest et al., 2008). Although there is evidence that vagal tone 
is generally higher in women than men (Ribeiro et al., 2001), (Sinnreich et al., 1998) 
progressive aging reduces the difference between the two genders. 
 
 
A key feature of physical exercise training is an enhancement of the CV system’s 
interactions, which includes the improvement in the neural regulatory aspects of cardiac 
regulation through the SA node (Tortora and Grabowski, 2000). Earnest et al. (2008) 
found that physical activity facilitated improvements in HRV in older women and that 






In general, the research pertaining to physical activity and its effects on HRV provides 
strong evidence that exercise training has beneficial effects in increasing HRV in all 
population groups if minimum guidelines are adhered to.  
 
1.8 Gender, Ageing and Heart Rate Variability 
The association between gender and HRV characteristics is controversial (Umetani et 
al., 1998, Sinnreich et al., 1998, Ryan et al., 1994, Ramaekers et al., 1998 ).When using 
HRV in clinical settings for predictive purposes, researchers have to take into account 
the impact of various important physiological factors. Two of these are prominent: 
gender and age. Research on age is widespread and it has been shown that HRV 




Heart rate variability is constant over a 1-year period in older adults who do not alter 
their activity level (Dietrich et al., 2006). Results of a study performed by Umetani et al. 
(1998) demonstrated that HRV decreases with aging. Importantly, it was found that this 
age related decline can affect the predictive value of HRV, principally in the aging 
population, by making it difficult to distinguish low HRV due to disease from that due 
to normal aging. Research has demonstrated that HVR decline occurs at a different rate 
in male and female subjects (Umetani et al., 1998).  
 
 
Therefore, gender also influences HRV but the research on gender differences is 
limited. Most of the data acquired has been incidental reports in studies that focused on 
other concerns (Dietrich et al., 2006, Kristal-Boneh et al., 2002, Lui et al., 2003). 
Available reports are controversial with some reporting a higher HRV for female 
(Sinnreich et al., 1998, Ramaekers et al., 1998) than for male subjects and others 
reporting the converse (Umetani et al., 1998). Some literature suggests that gender 
differences and age could have more prognostic traits (Ribeiro et al., 2001). The aging 
process results in HRV decreases placing individuals at a greater risk of developing 
CVD (Dietrich et al., 2006). Gender differences may also aid in diagnosis and 
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identifying risk factors for CVD. Research predominately suggests females have an 
overall higher HRV than males (Lui et al., 2003).  
 
 
Umetani et al. (1998) observed that gender differences are most pronounced in young 
(30 years) subjects. The HRV of young male subjects were significantly greater than 
that of age matched female subjects, indicating greater parasympathetic tone in males. 
However, differences disappear by age fifty (Umetani et al., 1998). Conversely, Ryan et 
al. (1994) found that vagal HF power was higher in females. They found that this 
difference is most apparent for young (20-39) and middle aged (40-64) females. 
Raemaeker et al. (1998) noted specifically that LFnu and the LF/HFnu ratio were higher 
in males, however HFnu showed no difference between the genders. Sinnreich et al. 
(1998) observed that the RMSSD and HF components (measures that reflect 
predominantly vagal activity) were small and non significant, but that the LF/HF ratio 
(suggested to reflect sympathovagal balance) differed substantially due to great VLF 
and LF power found in the male participants. They concluded that their results 
illustrated relatively higher sympathetic activity in men compared to women (Sinnreich 
et al., 1998). 
 
 
Gender differences in the association between duration of type 2 diabetes and HRV 
have also been investigated (Nolan et al., 2004). Among males, duration of diabetes was 
independently and inversely associated with vagal HR modulation and total RR 
variability but this was not apparent in females. In contrast, HF was inversely associated 
with age of diabetes diagnosis and 10-year absolute risk for CVD among female 
subjects. Longitudinal research is needed to establish whether risk factors for early 
cardiac autonomic impairment differ among men and women with type 2 diabetes 
(Nolan et al., 2004).  
 
Cardiovascular disease is a leading cause of death in many developed countries. The 
relation between oestrogen and CVD has been discussed in many epidemiological 
studies. Research surrounding CVD has suggested that premenopausal females have a 
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reduced risk of CVD compared to males and postmenopausal women (Lui et al., 2003). 
Evidence shows that the incidence of CVD increases after menopause in women and 
that the CV mortality rate of postmenopausal women with oestrogen replacement 
therapy is lower than that of women who do not take it. To explain the mechanism of 
this phenomenon, the effects of oestrogen on the lipid profile and vascular activity have 
been discussed and established in studies (Lui et al., 2003). Moodithaya et al. (2009) 
examined the effect of oestrogen as a possible reason for young females having higher 
HRV and a cardio-protective mechanism compared to older females and/or their male 
counterparts. The authors demonstrated that postmenopausal women have a 
significantly reduced overall fluctuation in autonomic input to the heart and vagal index 
of HRV. This was reflected by postmenopausal women having a lower total power and 
HF in absolute power compared to young women which was associated with oestrogen 
levels (Moodithaya and Avadhany, 2009, Ribeiro et al., 2002). Additionally, it was 
demonstrated that oestrogen administration in premenopausal women attenuated 
vasoconstrictor responses to norepinephrine and reduced total body norepinephrine 
spillover, which is an index of sympathetic neural activity (Lui et al., 2003). 
 
 
In conclusion most of the evidence provided strongly suggests that females have a 
higher HRV before they reach menopause. This finding supports research indicating 
that women have a cardio-protective mechanism due to higher oestrogen levels 
premenopause. Progressive aging has been widely reported to decrease HRV. Therefore 
taking gender and age into account facilitates a more accurate demarcation of the 
normal range of HRV and HR, which could help to improve the diagnostic and 
predictive usefulness of HRV in clinical settings (Umetani et al., 1998). 
 
 
1.9 Reliability and Validity of Heart Rate Variability Measurements 
Reliability can be defined as the ability to replicate a measurement from day to day by 
the same observer in identical conditions thus rendering it reliable (Petrie and Sabin, 
2000). The reliability of HRV has been frequently investigated yet remains poorly 
quantified (Taskforce, 1996). Assessing the reliability of a measure that evaluates 
dynamic physiological processes is a complex task (Sandercock et al., 2007). It has also 
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been recommended that precision of measurements of all new commercially available 
HRV technologies be assessed to validate the instrument (Nunan et al., 2009, Taskforce, 
1996). Too establish the use of HRV, standardization of HRV protocols and parameters 
are required. Repeatability studies can assist in the process of standardizing HRV 
protocols and parameters. Few studies have examined the repeatable characteristics of 
HRV with regards to day to day readings in different population groups (Taskforce, 
1996).  
 
Pinna et al. (2007) performed an in-depth assessment of absolute and relative reliability 
of standard indexes of short-term laboratory HRV recordings in subject with 
spontaneous and paced breathing. These researchers found that HRV parameters are 
subject to large day to day random variations depicting decreased repeatability qualities. 
They concluded that random error of HRV parameters was in part due to sampling 
variability of the estimated parameters. Observed differences between individuals 
mostly reflected differences in a subject’s true value rather than random error (Pinna et 
al., 2007, Sandercock et al., 2007). Sinnreich et al. (1998) found that short term 
recordings of HRV had a high reliability coefficient and low coefficient of variation 
(which includes biological variability and method error) that indicated a considerable 
consistency with time.  
 
 
Sandercock et al. (2005) undertook a review of literature on the reliability of short term 
measurements of HRV. This review reported that statistical analysis plays an important 
role in reporting reliability and therefore the authors only included studies that used 
appropriate statistics. Furthermore, methodology and sample size were also controlled 
for due to the sensitivity of HRV (Sandercock et al., 2007). The aim of this literature 
review was to determine whether HRV measures made at rest or during specific 
interventions are reliable in healthy subjects and clinical populations. Short-term (5 
min) recordings were reported to have a number of advantages, including testing under 
various conditions which allows researchers to compare recordings so that they can 
observe autonomic responses to different stimuli or interventions. These recordings 
were shown to be well controlled, easy and quick to perform and analyse (Sandercock et 
al., 2005). The review concluded that there is a small effect of test–retest duration on 
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reliability and no single HRV measurement appears less reliable than another. However, 
they suggested that describing HRV as a reliable measurement technique appears to be a 
generalization, as results of reliability studies are varied, and dependent on a number of 
factors (Sandercock et al., 2005).  
 
 
A study examining a commercially available heart rate monitor (HRM), the Polar S810, 
provided information on the validity and reliability of this equipment for analysis of 
HRV. The findings of the study were that the Polar S810 provided a valid measure for 
most HRV parameters. The results from the Polar S810 demonstrated that this piece of 
equipment should not be used to detect small changes in HRV (Nunan et al., 2009).  
 
 
Weippert et al. (2010) conducted research on the comparison of three mobile devices 
for measuring IBIs and HRV: two breast belt systems, the Polar S810i HRM and the 
Suunto t6 HRM, and an ambulatory ECG system. With respect to IBI measurements, it 
was found that the three instruments can be used interchangeably. In this study, spectral 
analysis techniques were shown to be uncomplicated for normalized HRV frequency 
measures but this was not the case when absolute values were used. The results 
concluded that the tested breast belt systems are reliable for long-term HRV analysis 
(Weippert et al., 2010).  There was also minimal bias between short-term HRV 
measures obtained by the three instruments. The results showed that these devices were 
unreliable when testing individuals as compared to large groups and it was not 
recommended to use different devices for an intra-individual HRV analysis study 
(Weippert et al., 2010).  
 
 
Many factors can affect HRV recordings such as mood, alertness and mental activity 
which are very difficult to control for in studies (Pinna et al., 2007). Other factors that 
can be controlled for should be noted. Time of day of HRV recording is important, early 
morning readings like those used in most repeatability studies are suggested (Pinna et 
al., 2007, Sinnreich et al., 1998).  Eating should be avoided together with the intake of 
caffeine which can increase HR and affect HRV readings. Heavy physical activity that 
is done in conjunction with HRV testing may provide inaccurate readings of elevated 
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sympathetic activity due to insufficient recovery period (Lopes and White, 2006). 
Sleeping patterns also affect HRV recordings. A lack of sleep can inhibit 
parasympathetic activity, therefore increasing HR (Tortora and Grabowski, 2000). 
Intake of other stimulants like alcohol and smoking should also be avoided as it dilates 




In conclusion, HRV has been shown to be under the influence of random error and 
within subject variation. These finding suggest that assessing treatment effects in 
individuals using HRV maybe complex (Pinna et al., 2007). Considering this factor, the 
assessment of performance changes maybe be difficult to calculate as HRV may not be 
able to detect minor alterations under different circumstances (Lamberts et al., 2009). 
Sample sizes and confounding factors should be more rigorously controlled for to aid 
reliability. Research surrounding reliability is still confounding due to inadequate 
methodology and statistical methods used for analysis. Therefore further reliability 





Research into HRV has increased steadily over the last few decades. This research has 
provided an insight to the control mechanisms of HRV and new techniques for testing 
HRV has made this process easier. However, despite well documented studies on HRV, 
certain aspects still require clarification as shown in this review of literature. 
Overtraining, gender and reliability of HRV is still poorly quantifiable. Conflicting 
research on these aspects makes standardization of HRV difficult, therefore decreasing 









CHAPTER 2: SCIENTIFIC PAPER PUBLICATION 
 
The following paper is published in the Cardiovascular Journal of Africa (CVJA) 2011 
Jun 25;22:1-7. The Appendix VII provides a copy of the accepted article as it appears in 
the journal. 
 
This study was undertaken in light of limited literature pertaining to the reliability of 
heart rate variability measurements and the contradictory information relating to gender 























HEART RATE VARIABILITY IN PHYSICALLY ACTIVE 





To evaluate the reliability of short term recordings (5 mins) of heart rate variability 




HRV time and frequency domain parameters were calculated in 44 physically active 
students (21 males and 23 females) over 4 consecutive days. A Suunto t6 heart rate 
monitor was used to obtain inter-beat intervals (IBI’s) that were then transferred to 
Kubios HRV Analysis Software. The relative reliability (intraclass correlation (ICC)) 
and absolute reliability, (typical error of measurement, TEM and typical error or 
measurement as a percentage, TEM %) of the HRV parameters were then calculated for 
Day 2 vs. Day 3  and Day 3 vs. Day 4, with Day 1 being a familiarization day. The 
following HRV parameters were calculated; 1) Time domain: Resting heart rate (RHR), 
R-R intervals (IBI), standard deviation of Normal to Normal intervals (SDNN), root 
mean square differences of the standard deviation (RMSSD), percentage of beats that 
changed more than 50 ms from the previous beat (pNN50); 2) Frequency Domain: Low 
frequency normalized units (LFnu), high frequency normalized units (HFnu), low 
frequency to high frequency ratio in normalized units (LF/HFnu). An analysis of 
variance (ANOVA) with Tukey post-hoc testing was performed to compare HRV 




The ICCs for both day 2 versus day 3 (REL 1) and day 3 versus day 4 (REL 2) indicated 
primarily good to excellent (>0.8) relative reliability. The lowest value was found in the 
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LF/HFnu ratio (ICC = 0.36) for males. Absolute reliability was low with TEM% greater 
than 10% for all HRV parameters, except IBI’s. Females demonstrated better relative 
(higher ICC’s) and absolute reliability (lower TEM and TEM%) compared to males for 
the frequency domain. The relative and absolute reliability for the time domains were 
similar except for SDNN where the absolute reliability was higher in males. ANOVA 
illustrated significant gender differences for the LF/HFnu ratio (41% higher in males, p 






Short term recordings of HRV over 3 consecutive days demonstrated a high relative 
reliability. However, a low absolute reliability indicated large day-to-day random 
variation in HRV which would make the detection of intervention effects using HRV 
difficult in individual participants. Females were shown to have a higher 
parasympathetic modulation of HRV which may indicate an underlying cardioprotective 
mechanism in females compared to males.  
 
Key words: Heart rate variability, sympathovagal balance, reliability. 
 
2.2 Introduction  
 
Heart rate variability (HRV) is recognized as a versatile and promising, non-invasive 
marker of autonomic nervous system (ANS) modulation (Weippert et al., 2010). 
Research into the use of HRV has increased in both clinical and research environments 
and over a broad spectrum of disciplines (Nunan et al., 2009, Pinna et al., 2007). 
However, in the disciplines of sport and exercise science, there is limited information 
available on the reliability of HRV measures, in particular related to new, commercially 
available equipment that coaches and athletes have access to. This fact, together with 
the extensive amount of variables that alter HRV measures, makes it difficult to 
compare HRV studies and develop a universal standard (Nunan et al., 2009). While 
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most studies agree that age is inversely associated with HRV (10) research is less 
consistent on the impact of gender with studies demonstrating that HRV measures are 
either the same or differ considerably between the genders and may also be HRV 
parameter dependant (Ramaekers et al., 1998 , Ryan et al., 1994, Sinnreich et al., 1998, 
Umetani et al., 1998). 
 
Heart rate variability reflects the changes in the interval between heart beats (R-waves) 
over time. The time between one R-wave and the next, in milliseconds, is termed the 
RR interval or the interbeat interval (IBI) (Algra et al., 1993). The ANS governs the 
IBI’s via the sympathetic and parasympathetic pathways (Aubert et al., 2003). The 
relative dominance of either pathway over the other represents an alteration in the 
sympathovagal balance which is reflected in IBI changes (Keenan and Grossamn, 
2006). Under normal resting conditions in healthy individuals it has been suggested that 
the parasympathetic pathway is dominant resulting in a high HRV (Algra et al., 1993), 
whilst lower HRV, and poor health, has been linked to increased sympathetic activity at 
rest (Lopes and White, 2006, Umetani et al., 1998).  However, research has 
demonstrated that the age, physical activity status, gender and the HRV parameter 
examined are important factors to consider when examining HRV (Ramaekers et al., 
1998, Ryan et al., 1994, Sinnreich et al., 1998, Umetani et al., 1998) . 
 
Research has identified the potential use of HRV for identifying healthy and diseased 
states. In particular, a significant relationship between the ANS, low HRV and 
cardiovascular mortality, including sudden cardiac death, has been reported (Ribeiro et 
al., 2001, Taskforce, 1996). In addition, studies have shown that trained athletes have 
higher HRV compared to sedentary individuals, suggesting that exercise training can 
increase HRV in normal populations (Nagai and Moritani, 2004). The overtraining 
syndrome is assumed to be consequence of an imbalance between long-term 
inappropriate high training volume and too little time for regeneration (Borresen and 
Lambert, 2008, Brooks et al., 2005). Alterations in the ANS have been presented as a 
mechanism underlying the signs and symptoms of the overtraining syndrome (Hynynen 
et al., 2006). A study which examined ANS activity in several middle distance runners 
suggested that heavy training shifted the cardiac autonomic balance toward a 
predominance of the sympathetic over the parasympathetic drive which was represented 




Heart rate variability has the potential to be a useful monitoring tool in the fields of 
health, fitness and sports performance. However, currently, there are issues regarding 
the standardisation and reproducibility of HRV measurement as there are many 
confounding factors that can influence HRV. These include factors such as mood, 
alertness, mental activity, gender and age (Freitas et al., 1997, Pinna et al., 2007, Ryan 
et al., 1994).  Whilst the research relating to gender differences is controversial (Freitas 
et al., 1997, Ramaekers et al., 1998, Umetani et al., 1998) the relationship between age 
and HRV has been well documented (Dietrich et al., 2006, Ryan et al., 1994, Sinnreich 
et al., 1998, Umetani et al., 1998). Reduced HRV is associated with progressing age and 
with an increased risk of cardiac events in clinically disease-free patients (Nagai and 
Moritani, 2004). 
 
The development of wireless heart rate monitoring equipment which has the ability to 
record IBIs has provided athletes, coaches, scientists and medical practitioners with 
mobile and easy to use systems that allow for the analysis of HRV. The commercially 
available Suunto t6 heart rate system (Suunto; Vantaa, Finland) is one such instrument 
that is widely used for monitoring heart rate during exercise. The validity of the Suunto 
t6 in measuring IBI for determining HRV has been reported recently (Weippert et al., 
2010). Whilst previous studies have examined the reliability of other commercially 
available devices (Polar S810) for measuring HRV (Nunan et al., 2009, Weippert et al., 
2010), there is limited information on the reliability of the Suunto t6 for HRV 
measurement (Roy et al., 2009, Weippert et al., 2010). Analysis of the IBI’s to 
determine HRV can be performed using custom software like Kubios Heart Rate 
Variability Software Version 2.0 (Biosignal Analysis and Medical Imaging Group, 
Department of Physics, University of Kuopio, Kuopio, Finland) (Roy et al., 2009, 
Tarvainen and Niskanen, 2008). To date there are few publications reporting the use of 
both the Suunto t6 and Kubios Software together (Roy et al., 2009). 
 
The primary aim of this study was therefore to investigate the reliability of Kubios 
Software HRV measures calculated from the Suunto t6 IBI’s in physically active 











This study was conducted on 50 physically active young adults (males n=25; females 
n=25), although data analysis was performed on 21 males and 23 females due to 
exclusion criteria discussed in the statistical analysis of the data (Table 2.1). There were 
significant differences between the genders in terms of height, mass and percent body 
fat, but no differences in age, BMI, waist to hip ratio or weekly physical activity levels 
(Table 2.1). Participation was voluntary, and written informed consent was obtained 
from all participants. The study was approved by the Institution’s Biomedical Research 
Ethics Committee (REF: BE111/010). Participants were excluded from the study if they 
experienced a cold or feverish illness in the month leading up to the study, were 
smokers, had a pre –existing heart condition either current or in the past, were pregnant, 
diabetic, had congestive heart failure, or acute or chronic renal disease, if they have a 
pacemaker, or were taking type 1A antiarrhythmics (quinidine, procainamide, 
disopyramide, or moricizine).  
 
 
Table 2.1: Mean (± SD) of demographic data by gender. 
 Males (n=21) Females (n=23) p 
Age (years) 21.17 (1.55) 19.75 (1.76) 0.45 
Height (cm) 177.3 (9.09) 160.5 (6.49) <0.0001* 
Weight (kg) 76.19 (14.69) 60.41 (9.64) 0.0001* 
BMI (kg/m2) 24.03 (2.64) 23.41 (2.89) 0.467 
Waist/hip ratio 0.88 (0.07) 0.85 (0.068) 0.123 
Percent Body Fat 13.73 (4.53) 18.63 (3.77) 0.0004* 
IPAQ  
(Kcals/week) 
5828(3806) 5491 (3751) 0.789 









2.3.2 Assessment of Physical Activity Status  
 
The International Physical Activity Questionnaire (IPAQ) is a validated questionnaire 
primarily designed for population surveillance of physical activity among adults (age 
range 15-69 years (Hagstromer et al., 2006)).  This questionnaire was used to classify 
the physical activity status of the participants in the week leading up to the first (Day 1) 
testing day. The IPAQ requires the summation of duration (in minutes) and frequency 
(days) for different categories of physical activity. Based on this information MET-
minutes/week are calculated with the MET minute scores being equivalent to 
kilocalories expended per week. The participants were then classified into low, 
moderate or high physical activity levels. On average, the participants in the study were 
classified as being in the moderate category with an average of 5828 Kcals (Table 2.1) 
expended per week (833 kcal expended per day). Moderate is defined by the IPAQ 
guidelines as a pattern of activity done on 3 or more days, at least 20 minutes per day 
and described as vigorous-intensity activity or 5 or more days of moderate-intensity 





Testing was conducted within the Human Performance Laboratory (HPL) at our 
institution. The temperature in the HPL was maintained at 22oC with 50% humidity. 
Participants were provided pre-test instructions the week before the testing to help 
control for factors that could alter heart rate variability readings. They were asked to 
avoid caffeine, eating, heavy physical activity, smoking, and alcohol intake for the 10 
hours preceding each laboratory visit. Each participant attended 4 testing sessions for 4 
days in a row at the same time of the day. Testing was performed between 7am-9am.  
 
On testing Day 1, which counted as the familiarisation day, each participant read the 
information sheet provided on the study, signed a written informed consent, completed 
a pre-test questionnaire (IPAQ) and medical history questionnaire. The medical 
questionnaire examined cardiovascular, metabolic and respiratory disease history 
(personal and family) as well as risk factors and signs and symptoms for these diseases. 
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In addition, participants provided information on their current medication and 
supplement intake. Height, mass, waist and hip circumferences and 3 site skinfolds 
(females: tricep, supra-iliac and mid thigh; males: chest, abdominal and mid-thigh) were 
then measured. Height and weight were recorded using a calibrated medical height 
gauge and balance scale (Detecto, Webb City, USA). A Harpenden skin fold calliper 
was used for skin fold measurements to calculate percent body fat using the Jackson and 
Pollock equations (Jackson et al., 1978, 1980). Body mass index (BMI) (mass 
(kg)/height (m2) and waist to hip ratio (waist:hip circumferences) were then calculated 
and the HRV measurement protocol was then followed.  
 
2.3.4 Heart Rate Variability Measurement 
  
The participants were fitted with the Suunto t6 heart rate monitor (HRM) (Suunto; 
Vantaa, Finland). The electrodes on the transmitter were wet with water and were 
placed on the chest against bare skin to ensure good skin contact. Participants were 
tested while lying supine with the total testing time lasting 20 minutes. This time was 
divided into 15 minutes of rest followed by a 5 minute measurement of IBI’s. The IBI’s 
were then transferred to a laptop (HP ProBook) computer where the data were stored in 
the Suunto Team Manager software programme (Firstbeat Technologies, Ltd; Jyvaskyla 
, Finland). The data were then exported as a text file to the HRV analysis software 
(Kubios Heart Rate Variability Software Version 2.0; Biosignal Analysis and Medical 
Imaging Group, Department of Physics, University of Kuopio, Kuopio, Finland) for 
analysis of the following HRV parameters 1) Time domain: Resting heart rate (RHR), 
R-R intervals (IBI), standard deviation of Normal to Normal intervals (SDNN), root 
mean square differences of the standard deviation (RMSSD), percentage of beats that 
changed more than 50 ms from the previous beat (pNN50); 2) Frequency Domain: Low 
frequency normalized units (LFnu), high frequency normalized units (HFnu), low 
frequency to high frequency ratio in normalized units (LF/HFnu). 
 
The Suunto t6 HRM and Kubios programme (Roy et al., 2009) comply with guidelines 
recommended by the Taskforce of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology standards for measurement of HRV 
(Taskforce, 1996) . Before processing, the IBI’s were manually corrected for ectopic/ 
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missed beats. There is currently no universal method for identifying and editing ectopic 
beats. The amount and type of editing of IBI data has different effects on various HRV 
indices (Salo et al., 2001). In the present study, manual editing or interpolation (Salo et 
al., 2001)  of the IBI’s intervals was performed using the following guidelines: If a 
significantly higher IBI (representing an ectopic beat) was noted then that reading was 
deleted and average of the two adjacent IBI’s replaced the deleted one. If a significantly 
lower value (representing a missed beat) was noted, that IBI was deleted and replace 
with the previous IBI.  If the ectopic or missed beats exceeded 20% of a participant’s 
overall 5 minute recording the participant was not included in the analysis (Nunan et al., 
2009). This occurred in six participants (4 males and 2 females) with the result that only 
44 participants were included in the final analysis (n = 21 males and n = 23 females).  
 
Once the IBI’s were imported into the Kubios programme the software automatically 
analyzed the HRV in both time and frequency domains. Power spectral analysis was 
performed using the Autoregressive (AR) algorithm in accordance with the 
recommendations (Taskforce, 1996) . The AR algorithm was used as it yields improved 
resolution especially for short term HRV measurements (Roy et al., 2009, Tarvainen 
and Niskanen, 2008). This algorithm creates a power spectral analysis with distinct 
frequency bands; namely high-frequency (HF), low-frequency (LF) and very low 
frequency (VLF). The LF component has been proposed as reflecting both sympathetic 
and parasympathetic effects on the heart and occurs in a band between 0.04 Hz and 0.15 
Hz. However, researchers noted that the low frequency band is influenced by 
baroreceptor mediated regulation of blood pressure and reflects predominantly 
sympathetic activity (Moodithaya and Avadhany, 2009). The HF (0.15 Hz - 0.4 Hz) 
band corresponds with respiratory sinus arrhythmia (RSA)  and is said to reflect 
parasympathetic activity (Moodithaya and Avadhany, 2009). Chemoreceptor processes, 
thermoregulation, and the rennin-angiotensin system have been linked with the VLF 
band. We did not use data collected from the VLF range for this study.  
 
 
2.3.5 Statistical Analysis 
 
The data were summarized using routine descriptive statistics (mean ± SD). Reliability 
measures were determined for day 2 versus day 3 and day 3 versus day 4. Absolute and 
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relative reliability of several HRV parameters was calculated using the procedures 
described by Hopkins (2000). Hopkins (2000) has argued that the statistical analysis 
used in reliability studies should include observed values and confidence limits of the 
typical error. These measures are sufficient to characterize the reliability of a measure 
and that they substantially enhance comparison of the reliability of tests, assays or 
equipment (Hopkins, 2000). 
 
Absolute reliability is the degree to which repeated measurements vary for individuals. 
This type of reliability is expressed either in the actual units of measurement or as a 
proportion of the measured values (dimensionless ratio) (Atkinson and Nevill, 1998). 
Absolute reliability was calculated using the typical error of measurement (TEM) and 
TEM as a percentage (%), expressed as % of the mean score (Hopkins, 2000). Sport and 
exercise science reliability studies have rarely reported the separate analysis of 
homoscedastic and heteroscedastic data (Atkinson and Nevill, 1998). These parameters 
show how the measurement error relates to the magnitude of the measured variable. 
When the amount of random error increases as the measured values increase, the data 
are said to be heteroscedastic. When there is no relation between the error and the size 
of the measured value, the data are described as homoscedastic (Hopkins, 2000).  
Homoscedastic errors are expressed in the actual units of measurement (TEM) but 
heteroscedastic data are measured on a ratio scale. With homoscedastic errors, the raw 
data is analysed with conventional parametric analyses, but heteroscedastic data is 
transformed logarithmically before analysis or investigated with an analysis based on 
ranks (Atkinson and Nevill, 1998). In the present study the HRV data for each 
parameter was examined using the technique described by Hopkins (2000) and was 
found to be homoscedastic. TEM and TEM% were calculated with 90% CI for Day 2 
vs. Day 3 and for Day 3 vs. Day 4, using a spreadsheet downloaded from 
http://www.newstats.org. The TEM is also known in statistical terms as the coefficient 
of variation (CV).  
  
Furthermore, for reliability studies it has been suggested that relative reliability is 
presented together with absolute reliability (Atkinson and Nevill, 1998). Relative 
reliability is the degree to which individuals maintain their position in a sample with 
repeated measurements and is represented in the form of correlation coefficients. In this 
study we used Interclass correlations (ICC) with 95% CI (Hopkins, 2000). The main 
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advantage of ICC over Pearson’s correlation is that it can be used when more than one 
retest is being compared with a test (Atkinson and Nevill, 1998). Various categories of 
reliability are based on the ICC. An ICC >0.8 is usually regarded as good to excellent 
reliability, whereas an ICC between 0.6 and 0.8 may be taken to represent substantial 
reliability (Pinna et al., 2007).  
 
In order to determine whether there were any gender differences in the HRV 
parameters, the data for each HRV parameter for days 2, 3 and 4 were combined and 
analysis of variance (ANOVA), with a Tukey post-hoc testing, was performed to 
compare males versus females. The data were analysed with STATISTICA version 8.0 





A total of 44 participants with complete data sets were analysed. The outcomes of the 
reliability analysis are presented in Tables 2.2 and 2.3 for Day 2 vs. Day 3 and Day 3 
vs. Day 4.  
 
2.4.1 Typical error of measurement 
The absolute reliability indices for the HRV parameters are shown in Table 2.2.  The 
data presented here offers precision estimates for single measurements of Suunto t6 
HRV and data for making decisions when monitoring changes or responses to 
interventions in individuals.  
 
Overall for both males and females, the results show that for most HRV frequency 
domain parameters the second comparison Day 3 vs. Day 4 had lower TEM values 
compared to the first Day 2 vs. Day 3. This slight decrease in the typical error of 
measurement (TEM) could be due to a familiarisation effect (Aubert et al., 2003). 
Females demonstrated better absolute reliability in the HRV frequency domain as 
demonstrated by lower TEM’s. Specifically, the TEM’s for Day 3 vs. Day 4 were lower 
in females for the LF/HFnu ratio (116% lower), 90% lower for HFnu (Day 2 vs. Day 3) 
and 68% lower for LFnu (Day 2 vs. Day 3). The lowest typical error of measurement as 
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a percentage (TEM%), was 11.5% and was found in the females for HFnu (Day 2 vs. 
Day 3). Time domain results had a low TEM% for IBIs (Day 2 vs. Day 3: 4.8 males and 
females; Day 3 vs. Day 4: 4.9 females and 4.1 males). Overall the TEM% was relatively 
high in most HRV parameters specifically for LF/HFnu (Day 2 vs. Day 3: 31.4% 
females and 48.1% males; Day 3 vs. Day 4: 29.7% females and 40.4% males). The 
TEM was similar for males and females for the time domain parameters, specifically, 
RMSSD, pNN50 and the IBI’s. However, the TEM for SDNN was 42% lower in the 
males (Day 3 vs. Day 4).  
 
 
2.4.2 Interclass Correlations 
The Interclass Correlations (ICCs) for REL 1 ranged between 0.36-0.88 for the AR 
frequency domains and 0.70-0.92 for the time domains (Table 2). For Day 3 vs. Day 4  
the ICC’s ranged between 0.72-0.86 for the AR frequency domains and 0.72-0.93 for 
the time domains. The ICCs for both Day 2 vs. Day 3 and Day 3 vs. Day 4 indicated 
good to excellent (>0.8) reliability correlations for IBI’s and pNN50 from the time 
domain results. RMSSD reliability was good to excellent with the exception of the 
males for Day 3 vs. Day 4 that showed substantial reliability of 0.79. SDNN variable 
results depicted substantial reliability for both Day 2 vs Day 3 and Day 3 vs Day 4.  
 
Reliability ICC’s for the frequency domain were lower compared to the time domain.   
The ICCs in the frequency domain were between 0.36 and 0.88 with the lowest value 
for these correlations being the LF/HFnu ratio (ICC = 0.36) for males. It was found that 
overall, the male participants had lower ICC’s when compared to females for the same 
HRV parameter in the frequency domain analysis. The ICC’s for most time domain 
parameters were similar between the males and females with the exception of the IBI’s. 
Males displayed high IBI ICC values (Day 2 vs. Day 3 = 0.90, Day 3 vs. Day 4 = 0.93) 
which indicated higher relative reliability compared to the females (Day 2 vs. Day 3 
=0.83, Day 3 vs. Day 4 =0.79). Time domain ICC’s that were similar between males 
and females were SDNN (Day 3 vs. Day 4), males (0.73) and females (0.72) and 
pNN50 (Day 2 vs. Day 3), males (0.86) and females (0.84). 
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Heart Rate Variability: Frequency Domain: Low frequency normalized units (LFnu), high frequency normalized units (HFnu), low frequency to high frequency 
ratio in normalized units (LF/HFnu). Time domain: R-R intervals (IBI), standard deviation of Normal to Normal intervals (SDNN), root mean square differences of 
the standard deviation (RMSSD), percentage of beats that changed more than 50 ms from the previous beat (pNN50); Reliability: Intraclass correlation (ICC) is 
expressed as mean (95% CI); Typical Error of Measurement (TEM) and Typical Error of Measurement as a percentage (TEM %) are expressed mean (90% CI).  
 
  Day 2 vs Day 3 (REL 1) Day 3 vs Day 4 (REL 2) 
HRV 
parameters 
 TEM  TEM (%) ICC  TEM  TEM (%) ICC 
LF/HF nu 
Ratio 
Female 0.25 (0.20-0.36) 31.4 (25.1-45.2) 0.80 (0.59-0.91) 0.24 (0.19-0.35) 29.7 (23.5-43.4) 0.83 (0.63-0.92) 
 Male 0.54 (0.41-0.78) 48.1 (36.5-69.5) 0.36 (0.08-0.69) 0.43 (0.33-0.62) 40.4 (31.0-58.3) 0.72 (0.41-0.88) 
        
HFnu Females 6.63 (5.13-9.38) 11.5 (8.9-16.2) 0.88 (0.74-0.94) 7.92 (6.13-11.21) 13.4 (10.3-18.9) 0.81 (0.61 - 0.92) 
 Males 12.58 (9.62-18.17) 24.6 (18.8-35.5) 0.55 (0.17-0.79) 8.95 (6.85-12.93) 16.7 (12.8-24.2) 0.78 (0.53 - 0.90) 
        
LFnu Female 7.78 (6.26-10.38) 17.8 (14.3-23.8) 0.84 (0.70-0.92) 7.26 (5.84-9.69) 17.2 (13.9-23.0) 0.86 (0.74 - 0.93) 
 Male 13.04 (10.41-17.70) 26.6 (21.2-36.1) 0.52 (0.19-0.74) 9.40 (7.50-12.76) 20.2 (16.11-27.4) 0.75 (0.54-0.88) 
        
IBIs Females 44.90 (35.21-61.98) 4.8 (3.8-6.6) 0.83 (0.67-0.91) 45.89 (35.99-63.34) 4.9 (3.9-6.9) 0.79 (0.60-0.89) 
 Males 53.46 (40.90-77.20) 4.8 (3.6-6.9) 0.90 (0.79-0.95) 46.46 (35.54-67.09) 4.1 (3.2-5.9) 0.93 (0.85-0.96) 
        
SDNN Females 28.83 (22.30-40.80) 31.2 (24.1-44.1) 0.77 (0.54-0.90) 35.58 (27.52-50.36) 32.2 (28.8-52.7) 0.72 (0.45-0.87) 
 Males 20.70 (15.83-29.89) 19.9 (15.2-28.8) 0.70 (0.40-0.87) 20.62 (15.78-29.78) 20.2 (15.4-29.1) 0.73 (0.45-0.88) 
        
RMSSD Females 17.29 (13.37-24.47) 20.5 (15.8-29) 0.92 (0.82-0.97) 20.12 (15.56-28.48) 22.6 (17.5-32) 0.91 (0.80-0.96) 
 Males 19.12 (14.63-27.62) 18.7 (14.3-27.1) 0.83 (0.64-0.91) 20.53 (15.71-29.65) 20.3 (15.5-29.3) 0.79 (0.55-0.89) 
        
pNN50 Females 9.56 (7.39-13.53) 19.1 (14.8-27) 0.84 (0.67-0.93) 8.80 (6.80-12.45) 18.7 (14.4-26.4) 0.87 (0.72-0.94) 





2.4.3 Gender Differences 
There were significant differences between males and females for resting HR (p < 
0.0001), R-R intervals (p < 0.0001) and for the frequency domain HRV parameters, 
HFnu (p = 0.020) and LF/HFnu ratio (p = 0.003) (Table 2.3). The female resting heart 
rate was 16% higher than the males (p < 0.0001) while the IBI’s were 21% higher in the 
males (p < 0.0001). The LFnu (p = 0.087) and LF/HFnu ratio (p = 0.003) was 13% and 
41% higher in the males respectively while the HFnu (p = 0.02) was 12% higher in the 
females. There were no significant differences between males and females in the HRV 
time domain parameters except for IBIs.  
 
Table 2.3: Comparison of mean (± SD) of Days 2, 3 & 4 of heart rate variability 
data by gender. 
 Men Women p 
Resting HR 
(b/min) 
55.09 (8.1) 65.84 (7.2) <0.0001* 
IBIs 
(milliseconds) 
1126 (169) 927.7 (101) <0.0001* 
LFnu 47.95 (17.93) 42.48 (18.43) 0.087 
HFnu 52.02 (17.73) 59.17 (17.16) 0.020* 
LF/HF nu Ratio 1.114 (0.710) 0.792 (0.522) 0.003* 
SDNN 103.1 (36.13) 93.39 (57.55) 0.252 
RMSSD 101.3 (43.75) 87.57 (59.44) 0.137 
pNN50 53.35 (18.71) 48.46 (22.77) 0.182 
 
LFnu = low-frequency nu; HFnu = high-frequency nu; LHnu = low-frequency nu 
to high-frequency ratio; SDNN = standard deviation of Normal to Normal interval, 
RMSSD = root mean squared differences of the standard deviation; pNN50 = 









Despite extensive use and research in both clinical and physiological settings, HRV 
analysis is still poorly supported by rigorous reliability studies (Pinna et al., 2007). The 
purpose of the present study was to examine the reliability and gender characteristics of 
standard parameters of HRV from short-term (5 minutes) laboratory recordings in 
physically active individuals. The main findings of this study were that the reliability of 
HRV recording over consecutive days varies depending on the specific reliability index 
used, the HRV parameter examined as well as the gender of the population. A 
comparison of HRV frequency domain parameters for males and females demonstrated 
significant gender differences in the sympathovagal balance. 
 
Although the definition of a categorical rating of relative reliability based on ICC’s is 
still controversial (Pinna et al., 2007), the results from the present study demonstrate 
substantial to excellent relative reliability for the majority of time and frequency domain 
HRV parameters when comparing measurements obtained from Days 3 and 4. For most 
measurements, the ICC was >0.80 (‘good’) (Atkinson and Nevill, 1998) indicating that 
the repeated measurements reflect mostly the true value of HRV parameters relative to 
random error. Females demonstrated a higher relative reliability than males for all 
frequency domain parameters. The high ICC  of these short term recordings indicate a 
considerable consistency with time similar to previous studies (Pinna et al., 2007, 
Sinnreich et al., 1998). 
 
However, absolute reliability, indicated by the TEM and TEM%, revealed the presence 
of a large random error in all HRV parameters, particularly for the males. Females 
demonstrate better absolute reliability (lower TEM) than males for all parameters 
particularly those in the frequency domain. The TEM% also indicated a low absolute 
reliability due to the high values found specifically for the LF/HFnu ratio. These 
findings are similar to those of Pinna et al (2007) who found a greater random error 
(TEM) in frequency domain measures  (Pinna et al., 2007). These results might place 
doubts for the use of HRV indices in assessing interventions or treatment affects in 
individual participants specifically when examining male participants or clinical 
populations (Pinna et al., 2007). Furthermore, these results place doubt in the use of 





high TEM and TEM% indicated that HRV would be unable to detect small but 
significant changes (≤ 1%) in performance (Lamberts et al., 2009). Considering the 
absolute reliability is low (high TEM and TEM% values), the large random error found 
in HRV would require improved changes in HRV to occur to deem them meaningful 
(Lamberts et al., 2009).   
 
 
2.5.1 Gender Differences 
 
Findings of research examining HRV gender differences in healthy individuals are 
conflicting (Ramaekers et al., 1998, Ryan et al., 1994, Sinnreich et al., 1998, Umetani et 
al., 1998). Research has demonstrated that HRV measures are either the same or differ 
considerably between the genders and may also be HRV parameter or age dependant 
(Ramaekers et al., 1998 , Ryan et al., 1994, Sinnreich et al., 1998, Umetani et al., 1998) 
and therefore, further research has been advocated (Aubert et al., 2003). Umetani et al. 
(1998) has shown that HRV (for all measures) is significantly lower in “young” (10-29 
yrs) females compared to their age-matched male counterparts. The gender differences 
subsequently decreased and then disappeared with age and at different rates for the 
HRV parameters. Their findings suggested a higher level of parasympathetic activity in 
males (Umetani et al., 1998). Conversely, Ryan et al. (1994) concluded that vagal high 
frequency power was higher in females. They suggested this difference is most apparent 
for young (20-39) and middle aged (40-64) females. Raemaeker et al. (1998) noted that 
the LFnu (sympathetic dominance) was higher in females however, HFnu 
(parasympathetic dominance) was not significantly different between the genders 
(Ramaekers et al., 1998 ). Sinnreich et al. (1998) observed that RMSSD and HF 
component (measures reflecting predominantly vagal activity) were small and non 
significant, but that the LF/HF ratio (suggested to reflect sympathetic/parasympathetic 
balance) differed substantially due to greater VLF and LF power found in the male 
participants. They concluded that their results illustrated relatively higher sympathetic 
activity in men compared to women. Our findings demonstrate a similar gender 
distinction to that of Ryan et al. (1994) and Sinnreich et al. (1998). A higher level of 
parasympathetic activity was found in the female participants compared to the males. 






The finding of a higher HRV and contribution of the parasympathetic nervous system to 
HRV in females may help explain the overall protection of premenopausal females from 
coronary heart disease (CHD), coronary mortality and sudden cardiac death, compared 
to males in this age group (Ribeiro et al., 2001, Sinnreich et al., 1998). Research has 
demonstrated that a high HRV is associated with improved cardiovascular health. 
Although not measured in the present study, the effect of oestrogen on HRV and 
parasympathetic activity in females may be a key factor in this finding. Research 
examining HRV in pre and postmenopausal women found a significant difference in 
HRV (Moodithaya and Avadhany, 2009). Post menopausal women had a significantly 
reduced HRV, as demonstrated by a higher relative power of LF and LF/HF ratio, 
which was related to a decline in the level of oestrogen. The authors concluded that a 
decline in the level of oestrogen from premenopausal to postmenopausal status favours 
the shifting of autonomic balance towards sympathetic dominance (Moodithaya and 
Avadhany, 2009). In support of this finding, research has demonstrated that 
physiological levels of oestrogen increase vagal tone and suppresses sympathetic 
modulation of heart rate in females (Lui et al., 2003). 
 
A limitation of this study was that respiratory rate was not controlled when measuring 
the IBI’s over the five minute recording period. Research has shown that the reliability 
of HRV measures is increased when respiratory rate is regulated (Lopes and White, 
2006). Furthermore, part of intra-subject variability is also due to the natural change of 
HRV parameters that occurs under the influences of factors such as mood, alertness and 





Heart rate variability measures are a popular, non-invasive tool used to monitor 
autonomic function. Short term recordings are easy to perform and are suitable for both 
clinical and physiological research. However, the findings of the present study have 
demonstrated a high relative reliability but low absolute reliability for HRV. In 
particular, HRV random error was higher in males. For clinical or sport/exercise science 
practice, these results place in doubt the use of HRV indices for assessing small (< 5%) 





populations (Pinna et al., 2007). Furthermore, these results place doubt on the use of 
HRV measurement for monitoring performance changes in well trained or elite athletes 
which typically require assessment techniques that can detect physiological or 
performance changes that are < 1% (29). Finally, specific HRV parameters differed 
between males and females indicating a greater parasympathetic modulation of HRV in 
females. This finding suggests a possible mechanism for why premenopausal females 
have a lower incidence of coronary heart disease compared to males in the same age 

































The findings of the present study indicate a large day to day random variation in 
repeated measurements when using the Suunto t6 HRM and Kubios custom HRV 
software to assess short-term HRV parameters in healthy, physically active individuals. 
The statistical analysis performed on the numerous HRV parameters suggested good to 
excellent relative reliability (ICC). However, both the absolute reliability indices, TEM 
and TEM%, were high, indicating a large within subject variation, particularly in males 
in the frequency domain parameters. This high absolute reliability questions the use of 
HRV for intervention studies or for the investigation of changes, as small alterations 
would not be detected (Pinna et al., 2007).  
 
Furthermore, in this study significant gender differences were found suggesting that 
women have a higher overall HRV compared to men. Higher LFnu and the higher 
LF/HFnu ratio which we have been observed in our male population can be attributed to 
higher sympathetic activity in males, this result is similar to findings by Ramaekers et 
al. (1998). Their observation on gender differences provided evidence that 
premenopausal women are at less risk of CHD and that females develop CV illness at a 
later age than males. Higher sympathetic activity has been linked to the development of 
CHD and a higher inclination to sudden cardiac death. At age 50 gender differences 
disappear (Umetani et al., 1998) and the rate of CHD in woman increase (Ramaekers et 
al., 1998). This observation suggests that younger premenopausal women have a cardio-
protective mechanism which maybe linked to increased levels in the hormone oestrogen 
(Ramaekers et al., 1998 , Lui et al., 2003).  
 
 
The results of the present study can provide a guideline when comparing clinical and 
normal population groups in this age category. However exercise interventions 
including the affect of different types of training (i.e. resistance training) necessitate 
further investigation on HRV and ANS. Exercise training has been shown to have a 
positive effect on HRV and therefore can improve health status of the population as 





syndrome (Berkoff et al., 2007, Seileret al., 2007). Furthermore our research into the 
statistical analysis of HRV has revealed that both relative and absolute reliability has to 
be calculated to provide adequate basis for reproducibility. Standardization of 
methodology of HRV and calculation of sample size is a crucial aspect of HRV 
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Five minute recordings of heart rate variability in physically active students: 
reliability and gender characteristics 
INFORMATION SHEET FOR PARTICIPANTS 
Thank you for showing an interest in this project.  Please read this information sheet 
carefully before deciding whether or not to participate.  If you decide to participate we 
thank you.  If you decide not to take part there will be no disadvantage to you of any 
kind and we thank you for considering our request.   
What is the Aim of the Project? 
This project is being undertaken as part of the requirements for a postgraduate degree in 
Biokinetics. The aim is to evaluate the stability of short recordings of heart rate 
variability (HRV) with time, and the association of HRV with age and sex. 
What Type of Participants are Needed? 
This study requires participants aged 19 to 24years. The age, gender, and racial 
characteristics of the volunteer group will be matched and volunteers will be excluded if 
they are or may have been pregnant; if they have diagnosed diabetes, congestive heart 
failure, or acute or chronic renal disease; if they have a pacemaker; or if they are 
currently taking type 1A antiarrhythmics (quinidine, procainamide, disopyramide, or 
moricizine). 
What will Participants be Asked to Do? 
Should you agree to take part in this project, you will be asked to fill out forms and be 
involved in a testing protocol. Written informed consent will be obtained from all 
participants, and the study will be approved by the University of KwaZulu-Natal 





We will examine participants in the Human Performance Laboratory situated in the 
Discipline of Sport Science at the University of KwaZulu-Natal. Each participant will 
attend 5 visits, each approximately 30 minutes long, for 5 days in a row at the same time 
of the day (7-9am). 
The following tests and evaluations will be performed: 
a) Personal/Medical History Form: you will be required to complete the enclosed 
personal/medical history form. The purpose of completing this form is to ensure that 
you meet the requirements to be included in the study, and that the researcher obtains 
necessary information about your lifestyle (including physical activity history) 
b) Testing Protocol: you will have your height, weight, BMI, waist and hip 
circumferences, 3 site skin folds and HRV reading over a 5 minute period will be 
recorded. 
Possible risks and discomforts: 
Resting Measures: Height, weight, and circumference measurements will produce no 
physical discomfort. 
Heart Rate Variability Monitoring: The participant will be required to wear a heart 
rate monitor across his/her chest, this should bring about minimal or no discomfort. 
Potential benefits of this study: 
This Study aims will provide baseline data for future use of HRV as a reliable tool in 
assessing various conditions. 
Please be aware that you may decide not to take part in the project without any 
disadvantage to yourself of any kind. 
Can Participants Change their Mind and Withdraw from the Project? 
You may withdraw from participation in the project at any time and without any 
disadvantage to yourself of any kind. 





The information will evaluate stability of short recordings of heart rate variability 
(HRV) with time, and the association of HRV with age and sex. 
 The information obtained will be used to provide baseline normative data. This will 
primarily allow the researcher to determine whether the use of HRV is a reliable and 
valid tool. 
 Results of this project may be published but any data included will in no way be linked 
to any specific participant. 
You are most welcome to request a copy of the results of the project should you wish. 
The data collected will be securely stored in such a way that only those mentioned 
above will be able to gain access to it.  At the end of the project any personal 
information will be destroyed immediately except that, as required by the University's 
research policy, any raw data on which the results of the project depend will be retained 
in secure storage for five years, after which it will be destroyed. 
What do participants have to avoid prior to testing? 
We will ask participants to avoid caffeine, eating, heavy physical activity, smoking, and 
alcohol intake for the 10 hours preceding each laboratory visit. We will identify 
individuals who have not been fasting for 10 hours or who smoked in the morning, but 
will not exclude protocol violators from participating in the study. 
What if Participants have any Questions? 
If you have any questions about our project, either now or in the future, please feel free 
to contact either:- 
Takshita Sookan   or Professor Andrew McKune 
Department of Sport Science    Department of Sport Science 
Telephone Number: 0826390875  University Telephone Number: 031 
2607394 
This project has been reviewed and approved by the Faculty Ethics Committeeof the 





                                                                         
Appendix II 
Informed Consent Sheet 
Consent to Participate in Research 
Dear ______________ 
You have been invited by Masters Candidate Takshita Sookan and Associate Professor 
Andrew McKune from the Discipline of Sport Science, University of KwaZulu-Natal, 
to participate in a study examiningfive minute recordings of heart rate variability in 
physically active students: repeatability and age–sex characteristics.  
The researcher will recruit 50 participants aged 19 to 24 years. The age, gender, and 
racial characteristics of the volunteer group will be matched and volunteers will be 
excluded if they are or may have been pregnant; if they have diagnosed diabetes, 
congestive heart failure, or acute or chronic renal disease; if they have a pacemaker; or 
if they are currently taking type 1A antiarrhythmics (quinidine, procainamide, 
disopyramide, or moricizine). 
PLAN AND PROCEDURES: 
Data 
(a) Contact Details: I agree to give basic information and contact details about myself to 
the researcher including my name, age (date of birth), address and phone number. 
(b) Medical History/Physical Activity Form: I agree to give information about my 
medical history and physical activity. The purpose of completing this form is to ensure 
that I meet the medical requirements to be included in this study and that the researcher 





(c) Baseline Data Collection: I agree to have my height, weight, waist and hip 
circumference, skinfold measurements, resting heart rate and heart rate variability 
readings for 5 minutes.  
RISKS AND DISCOMFORTS 
Baseline Measurements: Measurement of height, weight, waist and hip circumference, 
heart rate, will produce no physical discomfort. Skinfold (testing body fat %) may 
produce slight discomfort for a few seconds when the skin is pinched to get a 
measurement but will disappear immediately after releasing skin.  
POTENTIAL BENEFITS 
To evaluate the stability of short recordings of heart rate variability (HRV) with time, 
and the association of HRV with age and sex. 
TERMINATION OF PARTICIPATION 
I understand that if the screening and data collection procedures provide evidence that 
the tests or activities cannot be safely performed , or if I have a pre-existing condition 
which will not allow me to participate in the study, I will be informed at that time and 
will not be included in the study. I understand that the investigator will explain the 
reason for the exclusion to me.  
COSTS/COMPENSTAION 
The policy of the University of Kwa-Zulu Natal does not provide for compensation or 
medical treatment to participants who are injured as a result of this research study. 
However, every effort will be made to make the tests and activities as safe as possible, 
with little risk of injury.  
CONFIDENTIALITY 
All data and information collected in this study will be maintained in complete 
confidence and privacy will be protected. I will not be identified in any report or 
presentation by name as a result of this study.  
---------------------------------------------------------------------------------------------------------- 





You may contact the investigators in this study Masters candidate Takshita Sookan 
(0826390875), Associate Prof Andrew McKune (031-260-7985), any time if you have 
questions about the research or if you are injured as a result of the research. 
You may contact the Biomedical Research Ethics Office on 031-260 4769 or 260 
1074 if you have questions about your rights as a research participant. 
Your participation in this research is voluntary, and you will not be penalized or lose 
benefits if you refuse to participate or decide to stop at any time. 
If you agree to participate, you will be given a signed copy of this document and the 
participant information sheet which is a written summary of the research. 
 
The research study, including the above information, has been described to me orally. I 
understand what my involvement in the study means and I voluntarily agree to 
participate. I have been given an opportunity to ask any questions that I might have 
about participation in the study. 
 
____________________      ____________________ 
Signature of Participant                            Date 
____________________   _____________________ 































Data Recording Sheet. 













Waist Circumference (cm):___________ 
Hip Circumference(cm):_________________ 
Waist to Hip Ratio_________________ 
 
3 Site Skinfold 
Females  Males 
 
1. Triceps: _______mm                              1) Pectoral:____________mm 
2. Suprailiac:_______mm                           2) Abdomen:___________mm 







 International Physical Activity Questionnaire. 
  
(October 2002) 
LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 
questionnaires. Long (5 activity domains asked independently) and short (4 generic 
items) versions for use by either telephone or self-administered methods are available. 
The purpose of the questionnaires is to provide common instruments that can be used to 
obtain internationally comparable data on health–related physical activity. 
Background on IPAQ 
The development of an international measure for physical activity commenced in 
Geneva in 1998 and was followed by extensive reliability and validity testing 
undertaken across 12 countries (14 sites) during 2000. The final results suggest that 
these measures have acceptable measurement properties for use in many settings and in 
different languages, and are suitable for national population-based prevalence studies of 
participation in physical activity. 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this 
will affect the psychometric properties of the instruments.  
Translation from English and Cultural Adaptation 
Translation from English is encouraged to facilitate worldwide use of IPAQ. 
Information on the availability of IPAQ in different languages can be obtained at 
www.ipaq.ki.se. If a new translation is undertaken we highly recommend using the 





consider making your translated version of IPAQ available to others by contributing it 
to the IPAQ website. Further details on translation and cultural adaptation can be 
downloaded from the website. 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website.  
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. 
(2000). Assessment of Physical Activity: An International Perspective. Research 
Quarterly for Exercise and Sport, 71 (2): s114-20. Other scientific publications and 
presentations on the use of IPAQ are summarized on the website. 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives. The questions will ask you about the time you spent being 
physically active in the last 7 days. Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make 
you breathe much harder than normal. Moderate activities refer to activities that take 










PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, 
course work, and any other unpaid work that you did outside your home. Do not include 
unpaid work you might do around your home, like housework, yard work, general 
maintenance, and caring for your family. These are asked in Part 3. 
 




 No Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part 
of your paid or unpaid work. This does not include traveling to and from work. 
 
2.  During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, heavy construction, or climbing up stairs as 
part of your work? Think about only those physical activities that you did for at 
least 10 minutes at a time. 
 
_____ days per week 
 
 No vigorous job-related physical activity Skip to question 4 
 
3.       How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work? 
 
_____ hours per day 






4. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads as part of your work? Please do not include walking. 
 
_____ days per week 
 
 No moderate job-related physical activity Skip to question 6 
 
5. How much time did you usually spend on one of those days doing moderate 
physical activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
6.        During the last 7 days, on how many days did you walk for at least 10 minutes at     a 
time as part of your work? Please do not count any walking you did to travel to or from work. 
 
_____ days per week 
 
 No job-related walking Skip to PART 2: TRANSPORTATION 
 
7. How much time did you usually spend on one of those days walking as part of your 
work? 
 
_____ hours per day 










PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places like work, 
stores, movies, and so on. 
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like a 
train, bus, car, or tram? 
 
_____ days per week 
 
 No traveling in a motor vehicle Skip to question 10 
 
9. How much time did you usually spend on one of those days traveling in a train, 
bus, car, tram, or other kind of motor vehicle? 
 
_____ hours per day 
_____ minutes per day 
 
Now think only about the bicycling and walking you might have done to travel to and 
from work, to do errands, or to go from place to place. 
 
10. During the last 7 days, on how many days did you bicycle for at least 10 minutes at a 
time to go from place to place? 
 
_____ days per week 
 
 No bicycling from place to place Skip to question 12 
 
11. How much time did you usually spend on one of those days to bicycle from 






_____ hours per day 
_____ minutes per day 
 
12. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time to go from place to place? 
 
_____ days per week 
 
 No walking from place to place Skip to PART 3: 
HOUSEWORK, HOUSE 
MAINTENANCE, AND 
CARING FOR FAMILY 
 
13. How much time did you usually spend on one of those days walking from place 
to place? 
_____ hours per day 
_____ minutes per day 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
 
This section is about some of the physical activities you might have done in the last 7 
days in and around your home, like housework, gardening, yard work, general 
maintenance work, and caring for your family. 
 
14. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like heavy 
lifting, chopping wood, shoveling snow, or digging in the garden or yard? 
 
_____ days per week 
 
 No vigorous activity in garden or yard Skip to question 16 
15. How much time did you usually spend on one of those days doing vigorous physical 






_____ hours per day 
_____ minutes per day 
 
16. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate activities like carrying 
light loads, sweeping, washing windows, and raking in the garden or yard? 
 
_____ days per week 
 
 No moderate activity in garden or yard Skip to question 18 
 
17.       How much time did you usually spend on one of those days doing moderate  
physical activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
18. Once again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do moderate activities 
like carrying light loads, washing windows, scrubbing floors and sweeping inside your home? 
 
_____ days per week 
 





19. How much time did you usually spend on one of those days doing moderate physical 






_____ hours per day 
_____ minutes per day 
 
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
 
This section is about all the physical activities that you did in the last 7 days solely for 
recreation, sport, exercise or leisure. Please do not include any activities you have already 
mentioned. 
 
20. Not counting any walking you have already mentioned, during the last 7 days, on how 
many days did you walk for at least 10 minutes at a time in your leisure time? 
 
_____ days per week 
 
 No walking in leisure time Skip to question 22 
 
21. How much time did you usually spend on one of those days walking in your leisure 
time? 
 
_____ hours per day 
_____ minutes per day 
 
22. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like aerobics, 
running, fast bicycling, or fast swimming in your leisure time? 
 
_____ days per week 
 






23. How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
24. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate physical activities like 
bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure 
time? 
 
_____ days per week 
 
 No moderate activity in leisure time Skip to PART 5: TIME 
SPENT SITTING 
 
25. How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
PART 5: TIME SPENT SITTING 
 
The last questions are about the time you spend sitting while at work, at home, while doing 
course work and during leisure time. This may include time spent sitting at a desk, visiting 
friends, reading or sitting or lying down to watch television. Do not include any time spent 
sitting in a motor vehicle that you have already told me about. 
 
26. During the last 7 days, how much time did you usually spend sitting on a weekday? 
 
_____ hours per day 






27. During the last 7 days, how much time did you usually spend sitting on a weekend 
day? 
 
_____ hours per day 
_____ minutes per day 
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